Literature DB >> 3799237

Serum amyloid A protein in acute myocardial infarction.

G Marhaug, L Hårklau, B Olsen, G Husby, A Husebekk, H Wang.   

Abstract

Tissue injury including myocardial infarction leads to a variety of changes in plasma proteins commonly referred to as "the acute phase response". In this report the concentrations of serum amyloid A protein (SAA) were measured serially in 6 patients with myocardial infarction and 4 with angina. SAA was found to be increased in all patients with infarction, but in no patients with angina. Significantly increased SAA levels were detected 12 hours after the peak level of creatine kinase, and the concentrations of SAA seemed to correlate to the amount of damaged tissue. The SAA-response was both faster and more extensive than the response of C-reactive protein (CRP), but the correlation between SAA and CRP was very good.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3799237     DOI: 10.1111/j.0954-6820.1986.tb02769.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  4 in total

1.  Acute phase response in cerebral infarction.

Authors:  J Syrjänen; A M Teppo; V V Valtonen; M Iivanainen; C P Maury
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

2.  Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis.

Authors:  B M Schreiber; M Veverbrants; R E Fine; J K Blusztajn; M Salmona; A Patel; J D Sipe
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

3.  Serum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarction.

Authors:  C P Maury; K J Tötterman; C G Gref; C Ehnholm
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

4.  CRP and SAA1 Haplotypes Are Associated with Both C-Reactive Protein and Serum Amyloid A Levels: Role of Suppression Effects.

Authors:  Yu-Lin Ko; Lung-An Hsu; Semon Wu; Ming-Sheng Teng; Hsin-Hua Chou
Journal:  Mediators Inflamm       Date:  2016-05-25       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.